Equels Thomas K.

Avg. Two Year Performance

(54%) Avg. Purchase Return
(24%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(18%)(37%)(38%)(54%)
Purchase Success Rate8 of 173 of 172 of 170 of 170 of 17
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

CEO & President, Director:

Holdings: 1.64M shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--